This inventor holds 1 USPTO granted patent. Top assignee: Cetus Oncology Corporation. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Sharon Auckerman
Introduction
Sharon Auckerman is a notable inventor based in Yountville, California. She has made significant contributions to the field of biotechnology, particularly in the area of wound healing. Her innovative work has the potential to impact the treatment of various medical conditions.
Latest Patents
Auckerman holds a patent for the "Use of recombinant colony stimulating factor-1 to enhance wound healing." This patent describes the use of colony stimulating factor, CSF-1, which is a lymphokine beneficial in treating or preventing bacterial, viral, or fungal infections, neoplasms, leukopenia, and wounds. The invention also addresses overcoming immunosuppression induced by chemotherapy or other causes. CSF-1 is produced in usable amounts through recombinant methods, including the cloning and expression of murine and human DNA sequences encoding this protein. She has 1 patent to her name.
Career Highlights
Sharon Auckerman has worked with Cetus Oncology Corporation, where she has been able to apply her expertise in biotechnology. Her role at the company has allowed her to focus on innovative solutions for medical challenges, particularly in oncology and wound healing.
Collaborations
Auckerman has collaborated with notable colleagues such as James Devlin and Peter Ralph. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Sharon Auckerman's work exemplifies the impact of innovation in biotechnology. Her contributions to wound healing through her patented inventions highlight the importance of research and collaboration in advancing medical science.